Cargando…
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report
INTRODUCTION: Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system. To date, optimal therapeutic approaches for neuromyelitis optica have yet to be defined. Natalizumab is highly effective in relapsing-remitting multiple sclerosis and might be considered as an...
Autores principales: | Lee, De-Hyung, Laemmer, Alexandra B, Waschbisch, Anne, Struffert, Tobias, Maihöfner, Christian, Schwab, Stefan, Linker, Ralf Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046517/ https://www.ncbi.nlm.nih.gov/pubmed/24886528 http://dx.doi.org/10.1186/1752-1947-8-155 |
Ejemplares similares
-
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
por: Lee, De-Hyung, et al.
Publicado: (2013) -
Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis
por: Waschbisch, Anne, et al.
Publicado: (2011) -
Relapse of neuromyelitis optica associated with oral progestin
por: Li, Li-Min, et al.
Publicado: (2018) -
Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
por: Ellrichmann, Gisa, et al.
Publicado: (2018) -
Vomiting in Neuromyelitis Optica: An Atypical Presentation
por: Zaidi, Syed M, et al.
Publicado: (2019)